X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (299) 299
pth (269) 269
parathyroid hormone (210) 210
female (195) 195
male (184) 184
index medicus (175) 175
endocrinology & metabolism (160) 160
parathyroid hormone - blood (156) 156
middle aged (145) 145
aged (103) 103
adult (95) 95
animals (93) 93
urology & nephrology (91) 91
osteoporosis (87) 87
calcium (82) 82
secondary hyperparathyroidism (72) 72
parathyroid-hormone (64) 64
parathyroid hormone - pharmacology (62) 62
rats (62) 62
calcium - blood (61) 61
hypoparathyroidism (59) 59
primary hyperparathyroidism (56) 56
hyperparathyroidism (50) 50
postmenopausal women (49) 49
vitamin d (49) 49
teriparatide (48) 48
bone (47) 47
parathyroid hormone - therapeutic use (47) 47
renal dialysis (46) 46
fragments (45) 45
immunoradiometric assay (44) 44
intact pth (42) 42
renal-failure (41) 41
parathyroid hormone - metabolism (40) 40
peptide fragments - blood (40) 40
aged, 80 and over (39) 39
biomarkers - blood (38) 38
bone turnover (38) 38
orthopedics (38) 38
hormones, hormone substitutes, and hormone antagonists (37) 37
parathyroid hormone - administration & dosage (36) 36
bone density - drug effects (34) 34
bone-mineral density (34) 34
endocrinology (34) 34
medical laboratory technology (34) 34
medicine & public health (34) 34
bones (33) 33
kidney failure, chronic - blood (33) 33
renal osteodystrophy (33) 33
analysis (32) 32
hemodialysis (32) 32
hypoparathyroidism - drug therapy (32) 32
therapy (32) 32
metabolism (31) 31
parathyroid (31) 31
turnover (31) 31
calcitriol (30) 30
cells (30) 30
diagnosis (30) 30
parathyroidectomy (29) 29
pth/pthrp receptor (29) 29
receptor (29) 29
assay (28) 28
parathyroid-hormone 1-34 (28) 28
bone and bones - metabolism (27) 27
endocrine system (27) 27
article (26) 26
fractures (26) 26
density (25) 25
hemodialysis-patients (25) 25
mice (25) 25
efficacy (24) 24
peptide fragments - pharmacology (24) 24
surgery (24) 24
bone density (23) 23
chronic kidney disease (23) 23
kidney failure, chronic - therapy (23) 23
long-term treatment (23) 23
medicine, research & experimental (23) 23
treatment outcome (23) 23
adolescent (22) 22
bone and bones - drug effects (22) 22
calcifediol (22) 22
care and treatment (22) 22
dialysis patients (22) 22
health aspects (22) 22
immunoassay - methods (22) 22
kidney failure, chronic - complications (22) 22
alfacalcidol (21) 21
cortical bone (21) 21
quality-of-life (21) 21
replacement therapy (21) 21
time factors (21) 21
chronic kidney disease-mineral and bone disorder - blood (20) 20
disease (20) 20
failure (20) 20
internal medicine (20) 20
nephrology (20) 20
parathyroid hormone - analysis (20) 20
pharmacology & pharmacy (20) 20
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (460) 460
French (11) 11
Spanish (8) 8
Japanese (6) 6
German (5) 5
Italian (3) 3
Russian (3) 3
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Bone and Mineral Research, ISSN 0884-0431, 04/2013, Volume 28, Issue 4, pp. 736 - 745
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 02/2019, Volume 104, Issue 7, pp. 2748 - 2756
Context: Calcium and vitamin D treatment does not improve reduced quality of life (QOL) in hypoparathyroidism. Recombinant human (rh) PTH(1-84) therapy... 
SURGICAL HYPOPARATHYROIDISM | PTH(1-84) | EFFICACY | CALCIUM | ENDOCRINOLOGY & METABOLISM | PARATHYROID-HORMONE | HORMONE 2 RECEPTOR | RECEIVING STANDARD TREATMENT | EPIDEMIOLOGY | CALCITRIOL
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 10/2013, Volume 28, Issue 10, pp. 2232 - 2243
ABSTRACT Untreated, hypoparathyroidism (hypoPT) is a state of hypocalcemia with inappropriately low plasma parathyroid hormone (PTH) levels and... 
METABOLISM | HORMONES AND RECEPTORS | CLINICAL TRIALS | HYPOPARATHYROIDISM | PARATHYROID GLAND | PARATHYROID‐RELATED DISORDERS | PARATHYROID HORMONE | CALCIUM/PHOSPHATE DISORDERS | PTH/PTHRP | calcium/phosphate disorders | parathyroid hormone | pth/pthrp | hormones and receptors | parathyroid gland | parathyroid-related disorders | clinical trials | hypoparathyroidism | metabolism | LYMPHATIC TRANSPORT | PTH | PARATHYROID-HORMONE 1-34 | PTHRP | PARATHYROID-RELATED DISORDERS | HEART-CELLS | POSTMENOPAUSAL OSTEOPOROSIS | PARATHYROID-HORMONE-1-34 | CALCIUM | CROSSOVER TRIAL | ENDOCRINOLOGY & METABOLISM | CHINESE HEALTHY-VOLUNTEERS | PHOSPHATE DISORDERS | LONG-TERM TREATMENT | CALCITRIOL | Biomarkers - metabolism | Parathyroid Hormone - pharmacokinetics | Hypoparathyroidism - drug therapy | Humans | Hypoparathyroidism - physiopathology | Middle Aged | Parathyroid Hormone - therapeutic use | Male | Parathyroid Hormone - pharmacology | Parathyroid Hormone - blood | Hormone Replacement Therapy | Vitamin D - blood | Time Factors | Hypoparathyroidism - blood | Electrocardiography | Magnesium - urine | Adult | Female | Vitamin D - analogs & derivatives | Aged | Blood Pressure - drug effects | Circadian Rhythm - drug effects | Magnesium - blood | Hypoparathyroidism - urine | Phosphates | Algorithms | Vitamin D | Parathyroid hormone | Hypoparathyroidism | Clinical trials | Calcifediol | Alfacalcidol
Journal Article
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2002, Volume 40, Issue 2, pp. 348 - 354
Journal Article
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, ISSN 1530-891X, 05/2016, Volume 22, Issue 5, pp. 523 - 532
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 11/2011, Volume 26, Issue 11, pp. 2727 - 2736
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e88237
Osteoporosis is a common disorder characterized by compromised bone strength that predisposes patients to increased fracture risk. Parathyroid hormone related... 
PLACENTAL CALCIUM-TRANSPORT | VITAMIN-D | SHORT-TERM TREATMENT | IN-VITRO | PTH-RELATED PROTEIN | BONE-FORMATION | MULTIDISCIPLINARY SCIENCES | EXTRACELLULAR CALCIUM | RAT OSTEOCLASTS | PEPTIDE PTHRP | SKELETAL DEVELOPMENT | Recombinant Proteins - therapeutic use | Kidney - pathology | Rats, Wistar | Calcium - metabolism | Humans | Half-Life | Male | Osteoporosis - drug therapy | Stem Cells - cytology | Cell Lineage - drug effects | Kidney - metabolism | Bone Marrow Cells - drug effects | Female | Membrane Transport Proteins - metabolism | Osteoclasts - pathology | Osteoporosis - blood | Kidney - drug effects | Bone Resorption - blood | Peptide Fragments - isolation & purification | Mice, Inbred C57BL | Osteoblasts - drug effects | Osteogenesis - drug effects | Parathyroid Hormone-Related Protein - isolation & purification | Bone Marrow Cells - pathology | Bone Resorption - drug therapy | Bone Resorption - complications | Osteoclasts - metabolism | Parathyroid Hormone-Related Protein - therapeutic use | Osteoblasts - pathology | Organ Size - drug effects | Animals | Osteoporosis - pathology | Bone Resorption - pathology | Stem Cells - drug effects | Peptide Fragments - therapeutic use | Osteoblasts - metabolism | Bone Marrow Cells - metabolism | Osteoclasts - drug effects | Drug therapy | Osteoporosis | Hormones | Drugs | Cell culture | Peptides | Calcium | Human parathyroid hormone | Kinases | Osteoblasts | Parathyroid hormone-related protein | Proteins | Bone resorption | Embryology | Biomedical materials | Bone growth | Calcium (blood) | Mineralization | Bone marrow | Biocompatibility | Growth factors | Bone strength | Parathyroid | Recombinant | Kidneys | Ovariectomy | Radioactive half-life | Reabsorption | Histology | Cell differentiation | Gene fusion | Hypotheses | Dental research | Bone mass | Parathyroid hormone | Stem cells | In vivo methods and tests | Mice | Recombinants | Bone | Osteogenesis | Kidney transplantation
Journal Article
The Lancet Diabetes and Endocrinology, ISSN 2213-8587, 2013, Volume 1, Issue 4, pp. 275 - 283
Background: Hypoparathyroidism results in impaired mineral homoeostasis, including hypocalcaemia and hyperphosphataemia. Treatment with high-dose oral calcium...